Skip to content

LSD: all studies

Page 11 of 282: studies 101 to 110 of 2,815, newest first. Back to the LSD overview

Research

Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.

Psychopharmacology May 17, 2025 Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland et al. 12 citations

The head twitch response (HTR) is a spontaneously occurring behavior in mice that is increased in frequency by serotonergic psychedelics. The mouse HTR is often used as a proxy for psychedelic-like drug effects, but limited information is available about sex differences in HTRs evoked by various classes of psychedelics (i.e., phenethylamines, lysergamides, tryptamines). To examine potential sex...

DOI: 10.1007/s00213-025-06795-x (opens in new tab) Full text (opens in new tab) 5-ht2a Head twitch response Mice Psychedelics hallucinogens +6

Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?

Journal of Psychopharmacology May 5, 2025 Jan Kehler, Morten Skøtt Thomsen Lindskov 3 citations

The recent resurgence of classical psychedelic compounds, specifically 5-HT2A receptor agonists, as potential therapeutics has led to numerous initiatives aimed at better understanding the mechanisms underlying their effects. Psychedelic compounds are commonly known as hallucinogens. One of the major outstanding questions in the field is whether altered states of consciousness-the...

Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series

Cephalalgia Reports May 1, 2025 Jonathan A. Leighton, Chieh Grace Lau, Aisha Savdo et al. 2 citations

Background Cluster headache is an excruciating condition for which standard treatments are usually insufficient. Evidence has accumulated that serotonergic psychedelic indoleamines including psilocybin and LSD can be effective in preventing attacks. Methods In this case series, nine patients with episodic and chronic cluster headache that didn’t respond to conventional treatments were treated...

Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.

European journal of anaesthesiology May 1, 2025 Mansi Dave, Ron Shore, Tracy Cupido et al.

Psychedelic drugs, known for their perception-altering properties, are gaining popularity in the treatment of mental health and pain disorders. As exploratory studies demonstrate clinical efficacy with few adverse events, it is expected that more patients will ingest psychedelic drugs. For therapeutic reasons, as with any drug, anaesthesiologists must be aware of its physiological effects and...

DOI: 10.1097/eja.0000000000002138 (opens in new tab) Full text (opens in new tab) Drug interactions Psychedelic medicine Anesthesia safety Surgical protocols +1

Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.

Drug safety May 1, 2025 Ahmed Al-Imam, Riccardo Lora, Marek A Motyka et al. 1 citation

Psychedelics are gaining attention for their therapeutic potential in modern and personalized medicine. Online forums such as Erowid provide valuable user insights, but analyses of these experiences using natural language processing (NLP) remain scarce. This study aims to utilize NLP, including sentiment and lexicon analysis, to examine user-generated experience reports on psilocybin-containing...

DOI: 10.1007/s40264-025-01530-z (opens in new tab) Full text (opens in new tab) Consciousness research Altered states Psychedelics Drug effects

Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers.

Journal of Psychopharmacology April 18, 2025 James D Morse, Soo Hee Jeong, Robin J Murphy et al. 3 citations

Microdosing is the practice of taking psychedelic drugs at doses that produce no or minimal perceptible subjective or behavioural effects. This study investigated the pharmacokinetics and pharmacodynamics of microdosed lysergic acid diethylamide (LSD). This was a Phase 1 double-blind placebo-controlled parallel-groups trial with 80 healthy male volunteers (four withdrawals due to anxiety)....

DOI: 10.1177/02698811251330747 (opens in new tab) Full text (opens in new tab) LSD Pharmacodynamics Psychedelics hallucinogens Microdosing sub-perceptual dosing +5

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Proceedings of the National Academy of Sciences April 14, 2025 Jeremy R Tuck, Lee E. Dunlap, Yara A Khatib et al. 32 citations

Decreased dendritic spine density in the cortex is a key pathological feature of neuropsychiatric diseases including depression, addiction, and schizophrenia (SCZ). Psychedelics possess a remarkable ability to promote cortical neuron growth and increase spine density; however, these compounds are contraindicated for patients with SCZ or a family history of psychosis. Here, we report the...

DOI: 10.1073/pnas.2416106122 (opens in new tab) LSD Neuroplasticity Neuropsychiatric disease Nonhallucinogenic +9

Identification of two lysergic acid diethylamide analogs, 1-(3-(trimethylsilyl) propionyl) lysergic acid diethylamide (1S-LSD) and 1-(2-thienoyl)-6-allyl-nor-d-lysergic acid diethylamide (1T-AL-LAD), in paper sheet products distributed on the internet.

Forensic Toxicology April 3, 2025 Rie Tanaka, Maiko Kawamura, Michiho Ito et al. 3 citations

Recently, numerous lysergic acid diethylamide (LSD) analogs have emerged as designer drugs globally. These compounds are mainly distributed as sheet products. In this study, two new LSD analogs were identified from sheet products. The structures of the compounds were determined by gas chromatography-mass spectrometry, liquid chromatography-photodiode array-mass spectrometry, liquid...

Synthesis and analytical characterization of 1-(2-thienoyl)-6-allyl-nor-d-lysergic acid diethylamide (1T-AL-LAD).

Drug Testing and Analysis April 1, 2025 Yuki Okada, Hiroki Segawa, Tadashi Yamamuro et al. 6 citations

Lysergic acid diethylamide (LSD) analogs have emerged as new psychoactive substances (NPS) since the mid-2010s, and new compounds continue to emerge for recreational use. Since the end of 2023, "1D-AL-LAD" appeared on X (formerly Twitter) and other websites. As for the compound "1D-LSD" (which also has "1D" in the name), several studies show that the ingredient of seized blotter paper printed...

DOI: 10.1002/dta.3747 (opens in new tab) Full text (opens in new tab) 1d‐al‐lad Chemical synthesis New psychoactive substances Chemical analysis +3

Analytical and behavioral characterization of 1-hexanoyl-LSD (1H-LSD).

Drug Testing and Analysis April 1, 2025 Simon D. Brandt, Pierce V. Kavanagh, Sarah Gare et al. 4 citations

The development of lysergic acid diethylamide (LSD) derivatives and analogs continues to inform the design of novel receptor probes and potentially new medicines. On the other hand, a number of newly developed LSD derivatives have also emerged as recreational drugs, leading to reports of their detection in some countries. One position in the ergoline scaffold of LSD that is frequently targeted...

DOI: 10.1002/dta.3767 (opens in new tab) Full text (opens in new tab) LSD Psychedelics hallucinogens Acid research Head‐twitch response +6